title: Reply to Scalone and Cortesi: "Cost-utility analysis of biologic therapies to treat chronic plaque psoriasis in Italy: the importance of using updated and adequate social tariffs to calculate QALYs".
authors: University of Rome Tor Vergata, Via Columbia 2, 00133, Rome, Italy, federico.spandonaro@uniroma2.it.
authors: Federico
authors: F
authors: Spandonaro
authors: Fabio
authors: F
authors: Ayala
authors: Enzo
authors: E
authors: Berardesca
authors: Sergio
authors: S
authors: Chimenti
authors: Giampiero
authors: G
authors: Girolomoni
authors: Patrizia
authors: P
authors: Martini
authors: Andrea
authors: A
authors: Peserico
authors: Barbara
authors: B
authors: Polistena
authors: Antonio Puglisi
authors: AP
authors: Guerra
authors: Gino Antonio
authors: GA
authors: Vena
authors: Gianfranco
authors: G
authors: Altomare
authors: Piergiacomo Calzavara
authors: PC
authors: Pinton
mesh_terms: D001691:Biological Therapy / Q000191:economics*; D005260:Female; D006801:Humans; D008297:Male; D011565:Psoriasis / Q000188:drug therapy* / Q000191:economics*